VolitionRX Analyst Ratings
VolitionRX Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/01/2023 | — | Benchmark | Downgrades | Buy → Hold | |
| 12/19/2022 | 140.35% | EF Hutton | → $6 | Initiates Coverage On | → Buy |
| 08/23/2022 | 100.29% | Maxim Group | $8 → $5 | Maintains | Buy |
| 08/15/2022 | 140.35% | Aegis Capital | $9 → $6 | Maintains | Buy |
| 11/16/2021 | 260.52% | Aegis Capital | $10 → $9 | Maintains | Buy |
| 03/10/2021 | 220.46% | Cantor Fitzgerald | → $8 | Initiates Coverage On | → Overweight |
| 01/25/2021 | 300.58% | Aegis Capital | $8 → $10 | Maintains | Buy |
| 08/19/2020 | 220.46% | Aegis Capital | $10 → $8 | Maintains | Buy |
| 05/06/2020 | 300.58% | Aegis Capital | → $10 | Initiates Coverage On | → Buy |
| 05/16/2018 | 140.35% | Maxim Group | → $6 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 02/01/2023 | - | 基准 | 评级下调 | 购买→Hold | |
| 2022年12月19日 | 140.35% | EF Hutton | →$6 | 开始承保 | →购买 |
| 2022年08月23日 | 100.29% | Maxim集团 | $8→$5 | 维护 | 买 |
| 2022年08月15日 | 140.35% | 宙斯盾资本 | $9→$6 | 维护 | 买 |
| 2021年11月16日 | 260.52% | 宙斯盾资本 | $10→$9 | 维护 | 买 |
| 03/10/2021 | 220.46% | 康托·菲茨杰拉德 | →$8 | 开始承保 | →超重 |
| 2021/01/25 | 300.58% | 宙斯盾资本 | $8→$10 | 维护 | 买 |
| 2020年08月19日 | 220.46% | 宙斯盾资本 | $10→$8 | 维护 | 买 |
| 05/06/2020 | 300.58% | 宙斯盾资本 | →$10 | 开始承保 | →购买 |
| 2018年05月16日 | 140.35% | Maxim集团 | →$6 | 开始承保 | →购买 |
What is the target price for VolitionRX (VNRX)?
VolitionRX(VNRX)的目标价是多少？
The latest price target for VolitionRX (AMEX: VNRX) was reported by Benchmark on February 1, 2023. The analyst firm set a price target for $0.00 expecting VNRX to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
基准公司于2023年2月1日报道了VolitionRX(美国证券交易所股票代码：VNRX)的最新目标价。这家分析公司将目标价定为0.00美元，预计VNRX将在12个月内下跌(跌幅可能为-100.00%)。去年有4家分析公司公布了评级。
What is the most recent analyst rating for VolitionRX (VNRX)?
VolitionRX(VNRX)的最新分析师评级是多少？
The latest analyst rating for VolitionRX (AMEX: VNRX) was provided by Benchmark, and VolitionRX downgraded their hold rating.
VolitionRX(美国证券交易所代码：VNRX)的最新分析师评级由Benchmark提供，VolitionRX下调了他们的持有评级。
When is the next analyst rating going to be posted or updated for VolitionRX (VNRX)?
VolitionRX(VNRX)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of VolitionRX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for VolitionRX was filed on February 1, 2023 so you should expect the next rating to be made available sometime around February 1, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公开财务报表，与VolitionRX的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。VolitionRX的最后一次评级是在2023年2月1日提交的，所以你应该预计下一次评级将在2024年2月1日左右的某个时候提供。
Is the Analyst Rating VolitionRX (VNRX) correct?
分析师对VolitionRX(VNRX)的评级正确吗？
While ratings are subjective and will change, the latest VolitionRX (VNRX) rating was a downgraded with a price target of $0.00 to $0.00. The current price VolitionRX (VNRX) is trading at is $2.50, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的VolitionRX(VNRX)评级被下调，目标价为0.00美元至0.00美元。VolitionRX(VNRX)目前的交易价格为2.50美元，超出了分析师的预测区间。